The rising prevalence of respiratory diseases and technological advancements drive significant market growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aerosol Drug Delivery Devices Market Size & Growth ...

Pope Francis was resting Saturday after an alarming setback in his two-week recovery from double pneumonia: Doctors had to put him on noninvasive mechanical ventilation following a ...

becoming the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, and launched a few weeks later. Third-quarter sales of $6 ...

If your cold symptoms won't quit, you may have something else. Doctors explain what it could mean if you've got a lingering ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

In Chicago public schools that adopted a stock inhaler program, more students who used a stock inhaler for asthma symptoms ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...

A program that supplies schools with stock inhalers was well received by school health personnel/nurses in Illinois, according to two posters presented here.Both posters were presented at the 2025 ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Dr. John Coleman, a pulmonary critical care doctor at Northwestern ... bronchial spasm” began as a coughing fit in which Francis inhaled vomit. The longer respiratory crisis Francis suffered ...